Skip to main content
OK BIOTECH logo

OK BIOTECH — Investor Relations & Filings

Ticker · 4155 ISIN · TW0004155007 TW Manufacturing
Open in API
Filings indexed 1,730 across all filing types
Latest filing 2025-04-10 Transaction in Own Shar…
Country TW Taiwan
Listing TW 4155

About OK BIOTECH

http://www.okbiotech.com

OK Biotech Co., Ltd. is a medical device company specializing in the research, development, manufacturing, and global distribution of diagnostic and home healthcare solutions. Established in 2004, the company focuses on blood glucose monitoring systems, including high-precision meters and test strips, alongside over-the-counter (OTC) hearing aids and multiple frequency therapy devices. OK Biotech provides comprehensive services ranging from product design to complete factory setup solutions, supporting partners from initial planning through to mass production. By leveraging advanced R&D and production technologies, the company delivers reliable OEM and ODM solutions designed for both personal wellness and professional clinical applications. Its commitment to technical innovation ensures the delivery of high-quality medical instruments and tailored healthcare support to a global market.

Recent filings

Filing Released Lang Actions
本公司董事會決議買回本公司股份
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from a company (4155 訊映) regarding a board resolution to repurchase its own shares. It details the buyback purpose, amount, price range, period, and compliance with relevant securities regulations. There are no financial statements or comprehensive financial data presented, only the decision and plan for share repurchase. This fits the definition of a Transaction in Own Shares (POS) filing, which reports the company's buyback activities.
2025-04-10 Chinese
114年03月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, chairman, general manager, and other executives. It shows the number of shares held, changes in holdings, and related information. This type of document is a report on personal share transactions or holdings by company directors and executives, which matches the definition of a Director's Dealing report. There is no indication that this is an announcement of voting results, a general regulatory filing, or a financial report. The document length is substantial and contains actual data on insider shareholdings, not just a notice or certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2025-04-09 Chinese
114年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It focuses on insider shareholdings and pledges, with no financial statements, earnings data, or meeting results. The content is consistent with a Director's Dealing report, which discloses personal share transactions or holdings by company directors and executives. The document length is about 3,000 characters, which is typical for such disclosures. There is no indication of it being an announcement of a report or a certification. Therefore, the most appropriate classification is Director's Dealing (DIRS).
2025-04-09 Chinese
114年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure related to the company's and subsidiaries' loan balances and endorsement guarantees for a specific month (March of year 114 in the Taiwanese calendar). It contains tabular data on financial limits and balances but does not include comprehensive financial statements or detailed analysis. The document length is very short (612 characters), and it appears to be a regulatory disclosure or compliance update rather than a full financial report. There is no indication of it being an annual or interim report, earnings release, or any other detailed report type. Given the nature and brevity, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-04-08 Chinese
114年3月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company, with comparative data to the previous year and explanatory notes. It is very short (766 characters) and contains no detailed financial statements or management discussion. It appears to be a regulatory or public disclosure of revenue figures rather than a full financial report or earnings release. There is no indication of an earnings announcement or detailed quarterly report, nor is it a notice of dividend, capital change, or management change. Given the nature and length, it fits best as a Regulatory Filing (RNS) which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2025-04-08 Chinese
113年度財務比率
Fund Information / Factsheet Classification · 90% confidence The document contains a financial data table showing key financial ratios and metrics for three fiscal years (111年度, 112年度, 113年度). The data includes financial structure, debt ratios, liquidity ratios, operational efficiency, profitability, and cash flow metrics. The document is relatively short (1007 characters) and presents summarized financial data without detailed financial statements or narrative analysis. It does not appear to be a full annual or interim report, nor an earnings release or management discussion. It resembles a brief financial factsheet or summary of key financial data over multiple years. Therefore, the best fitting category is Fund Information / Factsheet (FS), which covers brief summaries of key company financials and facts.
2025-03-24 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.